col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

62 Results       Page 1

Elsevier: Schizophrenia Research
  original article Date Title Authors   All Authors
1 [GO] 2024―Apr―10 COVID-19 pandemic and emergency department visits for psychosis: Visit volume, restraint use, medication use, psychiatric hospitalization, and length of stay Brittany M. Gouse, Rachel Oblath, Jada S. Gibbs, Ellen G. Reagan, Hannah E. Brown
2 [GO] 2024―Mar―25 Association between discrimination and subsequent psychotic experiences in patients with COVID-19: A cohort study Zui Narita, Megumi Hazumi, Mayumi Kataoka, Kentaro Usuda, Daisuke Nishi
3 [GO] 2024―Feb―19 Tardive dyskinesia's under-recognition in the era of COVID-19 Derek Zhang, Samuel Law, Saadia Sediqzadah
4 [GO] 2023―Nov―14 Longitudinal observations of the severity of COVID-19 infection and its impact on clozapine/norclozapine levels and clozapine toxicity in patients experiencing multiple episodes Kimberly Clinebell, Jane Thomas, Melanie Yabs, K.N. Roy Chengappa
5 [GO] 2023―Sep―15 Letter to the editor: Clozapine plasma levels under co-medication with fluvoxamine during COVID-19 infection: A case report Maxim Kuzin, Carla Boeglin, Georgios Schoretsanitis, Manjinder Pannu, Wolfram Kawohl, Franziskos Xepapadakos
6 [GO] 2023―Sep―08 COVID-19 vaccination among patients with schizophrenia prescribed clozapine Yachana Panchal, Jessica M. Gannon, Janina-Marie Tatar, G.K. Balasubramani
7 [GO] 2023―Aug―23 Psychotic experiences, perceived stress, and suicidal ideation among the general population during the COVID-19 pandemic: Findings from Japan Andrew Stickley, Aya Shirama, Tomiki Sumiyoshi
8 [GO] 2023―Jul―14 Increasing disparities in cancer screening among people with severe mental illness during the COVID-19 pandemic Masaki Fujiwara, Yuto Yamada, Taichi Shimazu, Naoki Nakaya, Shiro Hinotsu, Maiko Fujimori, et al. (+2)
9 [GO] 2023―Mar―28 Potential mechanisms between psychotic-like experiences and suicidal ideation in the context of COVID-19: A longitudinal study Yue Li, Liang Zhou, Dongfang Wang, Ling Jing, Meng Sun
10 [GO] 2023―Mar―09 Memantine treats psychosis and agitation associated with Moderna COVID-19 vaccine Wen-Huei Siao, Fang-Yu Chang, Yi-Chyan Chen
11 [GO] 2023―Feb―10 Schizophrenia and COVID-19: A bibliometric analysis of trends and themes Suraj Kushe Shekhar
12 [GO] 2023―Jan―23 Psychotic-like experiences during COVID-19 lockdown among adolescents: Prevalence, risk and protective factors Dongfang Wang, Liang Zhou, Chunping Chen, Meng Sun
13 [GO] 2023―Jan―20 Epidemiology of infection, transmission and COVID-19 outcomes among mental health users and workers in a comprehensive network of long-term mental health facilities: Retrospective observational population-base study Manuel Canal-Rivero, Javier Vázquez-Hernández, Marta León-Gómez, Silvia Maraver-Ayala, Luis Fernández-Portes, Soraya Sánhez-Benítez, et al. (+3)
14 [GO] 2023―Jan―03 Prevalence of psychological reactions and suicidal ideation during one year of the COVID-19 pandemic in patients with severe mental disorders Leticia González-Blanco, Pilar A. Sáiz, Francesco Dal Santo, Leticia García-Álvarez, Luis Jiménez-Treviño, Gonzalo Paniagua, et al. (+3)
15 [GO] 2022―Oct―12 A profile of high scores on the Peters delusion inventory and low engagement in pandemic-related health behaviors in a non-clinical sample Michael Joseph Minzenberg, Jong H. Yoon
16 [GO] 2022―Jun―27 Worsening of psychotic experiences in college students during the COVID-19 pandemic J. Zimmerman, N.R. DeTore, W. Deng, A. Burke, M. Nyer, D.J. Holt
17 [GO] 2022―Jun―06 A call to action: Increased mortality from COVID-19 among individuals with schizophrenia calls for coordinated vaccination efforts Shayna H. Schor, Jada S. Gibbs, Brittany M. Gouse, Hannah E. Brown
18 [GO] 2022―May―19 COVID-19 infection, fluctuations in the clozapine/norclozapine levels and metabolic ratio and clozapine toxicity: An illustrative case-report K.N. Roy Chengappa, Jane Thomas, Charles E. Kahn, Kimberly Clinebell, Kelly K. Mullen, Lori Arbutiski, Emil Ivanov
19 [GO] 2022―Mar―04 COVID-19 contamination and severity among patients with schizophrenia: Results from a specialized outpatient clinic survey Carlos Gustavo Costardi, Fernando Malinowski, Lais Fonseca, Luciene Redondo, Cristiano Noto, Ary Gadelha
20 [GO] 2022―Feb―26 Negative schizotypy attenuates the effect of momentary stress on social dysfunction related to COVID-19 social distancing Michael D. Masucci, Victoria Martin, Thanh P. Le, Alex S. Cohen
21 [GO] 2022―Feb―17 Adaptive and maladaptive consequences of increased social media and internet use during the COVID-19 pandemic in schizophrenia Luyu Zhang, Gregory P. Strauss
22 [GO] 2022―Feb―01 Pandemic paranoia, general paranoia, and their relationships with worry and beliefs about self/others - A multi-site latent class analysis Suzanne Ho-wai So, Chen Zhu, Tania M. Lincoln, Brandon A. Gaudiano, Jessica L. Kingston, Lyn Ellett, Eric M.J. Morris
23 [GO] 2022―Jan―24 Olanzapine, risperidone and quetiapine: Do these atypical antipsychotics have a protective effect for SARS-CoV-2? Cintia R. Prokopez, Romina Farinola, Miguel Vallejos, Lorena S. Lopredo, Luciano E. Sfriso, Luciana C. Chiapella, et al. (+4)
24 [GO] 2022―Jan―24 First episode psychosis following receipt of first dose of COVID-19 vaccine: A case report Sandeep Grover, Seema Rani, Komal Kohat, Sanjana Kathiravan, Garima Patel, Swapnajeet Sahoo, et al. (+3)
25 [GO] 2022―Jan―10 Clozapine toxicity and coronavirus disease 2019: A case report Maria Sagué-Vilavella, Hugo López-Pelayo, Néstor Arbelo, Mercè Cámara, Susana Gomes, Santiago Madero, et al. (+2)
26 [GO] 2022―Jan―05 Correlates of Psychotic Like Experiences (PLEs) During Pandemic: An Online Study Investigating a Possible Link Between the SARS-CoV-2 Infection and PLEs Among Adolescents Helin Yilmaz Kafali, Serkan Turan, Serap Akpınar, Müge Mutlu, Aslınur Özkaya Parlakay, Esra Çöp, Timothea Toulopoulou
27 [GO] 2021―Dec―22 An overall protective effect of antipsychotic drugs against COVID-19 seems implausible Ángel Ruiz de Pellón-Santamaría, Cristina Sarasqueta-Eizaguirre, Francisco Javier Basterrechea-Peña
28 [GO] 2021―Sep―16 Psychotic behaviors during COVID-19: Should conspiracist ideation be included within the continuum model of psychosis? Álex Escolà-Gascón, Abigail C. Wright
29 [GO] 2021―Sep―14 COVID-19 dimensions and psychotic experiences among US college students: Findings from the Healthy Mind Study 2020 Hans Oh, Jessica Goehring, Ravi Rajkumar, Megan Besecker, Sasha Zhou, Jordan E. DeVylder
30 [GO] 2021―Sep―01 H1N109 pandemic research in people with schizophrenia providing insights into COVID-19 clinical care Paul A. Maguire, Rebecca E. Reay, Jeffrey C.L. Looi
31 [GO] 2021―Sep―01 Mediating role of metacognitive beliefs and cognitive-attentional syndrome in the relationship between persecutory and coronavirus conspiracy beliefs in a community sample Joachim Kowalski, Łukasz Gawęda
32 [GO] 2021―Sep―01 Changes of psychotic-like experiences and their association with anxiety/depression among young adolescents before COVID-19 and after the lockdown in China Zhipeng Wu, Zhening Liu, Zhulin Zou, Feiwen Wang, Mengran Zhu, Wen Zhang, et al. (+3)
33 [GO] 2021―Aug―07 Incidence and outcome of COVID-19 in patients with schizophrenia: A Study from India Sandeep Grover, Sanjana Kathiravan, Aarzoo Suman, Chandrima Naskar, Aseem Mehra, Swapnajeet Sahoo, Subho Chakrabarti
34 [GO] 2021―Jul―30 Adherence to recommended health and social distancing precautions during the COVID-19 pandemic in individuals with schizophrenia and youth at clinical high-risk for psychosis Kelsey I. Macdonald, Michael J. Spilka, Lisa A. Bartolomeo, Ian M. Raugh, Alysia M. Berglund, Gregory P. Strauss
35 [GO] 2021―Jul―30 Can antipsychotic use protect from COVID-19? Luiz Dratcu, Xavier Boland
36 [GO] 2021―Jul―22 Starting clozapine in patients with schizophrenia during the ongoing pandemic Sandeep Grover, Chandrima Naskar, Swapnajeet Sahoo, Aseem Mehra, Subho Chakrabarti
37 [GO] 2021―Jul―14 The immediate impact of the COVID-19 pandemic on attenuated positive symptoms and functioning in individuals at clinical high risk for psychosis: A pilot study Ricardo E. Carrión, Andrea M. Auther, Danielle McLaughlin, Barbara A. Cornblatt
38 [GO] 2021―Jul―08 The role of antipsychotics against COVID-19: A topic for debate M. Canal-Rivero, R. Catalán-Barragán, A. Rubio-García, N. Garrido-Torres, B. Crespo-Facorro, M. Ruiz-Veguilla, et al. (+4)
39 [GO] 2021―Jul―02 Sedentary behaviour in young people presenting with a first episode of psychosis before and during the covid-19 pandemic restrictions Brian O'Donoghue, Emily Castagnini, Alison Langstone, Nathan Mifsud, Andrew Thompson, Eoin Killackey, Patrick McGorry
40 [GO] 2021―Jun―26 Letter on: “Lower risk of SARS-CoV2 infection in individuals with severe mental disorders on antipsychotic treatment: A retrospective epidemiological study in a representative Spanish population” Ahmad Amjed Toubasi
41 [GO] 2021―Jun―23 An analysis of the possible protective effect of antipsychotics for SARS-CoV-2 in patients under treatment for severe mental illnesses Cintia R. Prokopez, Miguel Vallejos, Lorena S. Lopredo, Luciano E. Sfriso, Luciana C. Chiapella, Claudio Arce, et al. (+4)
42 [GO] 2021―Jun―16 New variants and new symptoms in COVID-19: First episode psychosis and Cotard's Syndrome two months after infection with the B.1.1.7 variant of coronavirus Umit Haluk Yesilkaya, Meltem Sen, Nesrin Karamustafalioglu
43 [GO] 2021―Mar―14 Changes in psychotic-like experiences and related influential factors in technical secondary school and college students during COVID-19 Meng Sun, Dongfang Wang, Ling Jing, Liang Zhou
44 [GO] 2021―Feb―21 Lower risk of SARS-CoV2 infection in individuals with severe mental disorders on antipsychotic treatment: A retrospective epidemiological study in a representative Spanish population M. Canal-Rivero, R. Catalán Barragán, A. Rubio García, N. Garrido Torres, B. Crespo-Facorro, M. Ruiz-Veguilla
45 [GO] 2021―Feb―21 Induced ideas of reference during social unrest and pandemic in Hong Kong Stephanie M.Y. Wong, Christy L.M. Hui, Corine S.M. Wong, Y.N. Suen, Sherry K.W. Chan, Edwin H.M. Lee, et al. (+3)
46 [GO] 2021―Jan―18 Factors associated with mask wearing among psychiatric inpatients during the COVID-19 pandemic Ha-Ran Jung, Cheol Park, Mina Kim, Min Jhon, Ju-Wan Kim, Seunghyong Ryu, et al. (+6)
47 [GO] 2020―Aug―06 The COVID pandemic and the endemic disparities in care across race for psychotic disorders Fabio Ferrarelli, Matcheri S. Keshavan
48 [GO] 2020―Jul―25 COVID-19 lockdown in people with severe mental disorders in Spain: Do they have a specific psychological reaction compared with other mental disorders and healthy controls? Leticia González-Blanco, Francesco Dal Santo, Leticia García-Álvarez, Lorena de la Fuente-Tomás, Carlota Moya Lacasa, Gonzalo Paniagua, et al. (+3)
49 [GO] 2020―Jul―25 Could the antipsychotic chlorpromazine be a potential treatment for SARS-CoV-2? B. Nobile, M. Durand, P. Courtet, P. Van de Perre, N. Nagot, J.P. Molès, E. Olié
50 [GO] 2020―Jun―15 The DOSMD challenge and the COVID-19 conundrum Ravi Philip Rajkumar
51 [GO] 2020―Jun―15 Unmask the mind! Importance of video consultations in psychiatry during COVID-19 pandemic Jagadisha Thirthalli, Narayana Manjunatha, Suresh Bada Math
52 [GO] 2020―May―28 Telephonic monitoring of patients on clozapine in the resource-poor setting during the COVID-19 pandemic Sandeep Grover, Eepsita Mishra, Subho Chakrabarti, Aseem Mehra, Swapnajeet Sahoo
53 [GO] 2020―May―27 The impact of COVID-19 on individuals living with serious mental illness Kareem Hamada, Xiaoduo Fan
54 [GO] 2020―May―26 Ensuring care for clozapine-treated schizophrenia patients during the COVID-19 pandemic Jessica Nichols, Jessica M. Gannon, Judith Conlogue, Deepak Sarpal, Jamie L. Montgomery, Robin Sherwood, et al. (+4)
55 [GO] 2020―May―16 The “mind” behind the “mask”: Assessing mental states and creating therapeutic alliance amidst COVID-19 Urvakhsh Meherwan Mehta, Ganesan Venkatasubramanian, Prabha S. Chandra
56 [GO] 2020―May―14 Clozapine treated patients and COVID-19: Ensuring continued care through collaboration Jonathan G. Leung, Terri S. Wittenberger, Kathryn M. Schak
57 [GO] 2020―May―13 Psychotic experiences in student population during the COVID-19 pandemic Michal Hajdúk, Daniel Dančík, Jakub Januška, Viktor Svetský, Alexandra Straková, Michal Turček, et al. (+4)
58 [GO] 2020―May―07 Long acting injectable antipsychotic medications: Ensuring care continuity during the COVID-19 pandemic restrictions Jessica M. Gannon, Judith Conlogue, Robin Sherwood, Jessica Nichols, Juliette R. Ballough, Noreen M. Fredrick, K.N. Roy Chengappa
59 [GO] 2020―May―06 The potential impact of COVID-19 on psychosis: A rapid review of contemporary epidemic and pandemic research Ellie Brown, Richard Gray, Samantha Lo Monaco, Brian O'Donoghue, Barnaby Nelson, Andrew Thompson, et al. (+2)
60 [GO] 2020―Apr―27 Long-acting injectable antipsychotics treatment during COVID-19 pandemic - A new challenge Petru Ifteni, Lorena Dima, Andreea Teodorescu
61 [GO] 2020―Apr―16 COVID-19, mobile health and serious mental illness John Torous, Matcheri Keshavan
62 [GO] 2020―Apr―04 Is schizophrenia research relevant during the COVID-19 pandemic? Henry R. Cowan

62 Results       Page 1


Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec